| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |